Data from the ARIC and AASK cohorts suggested that the loss of GSTM1 increased the risk of kidney failure or accelerated CKD progression (Chang et al., 2013; Bodonyi-Kovacs et al., 2016; Tin et al., 2017). The gene discussed is GSTM1; the disease is kidney failure.